Microsoft’s forecast suggests gloomy tech environment will continue
Microsoft’s business weakened in December. Now it expects those patterns to continue to play out through March, including in its critical Azure cloud.
Microsoft shares are ‘just north’ of expensive after reporting earnings, Tim Seymour says
Microsoft shares were higher initially in extended trading after the tech giant reported earnings, then dipped lower.
Trump drops second legal challenge to New York attorney general after sanctions in Hillary Clinton case
Donald Trump was sanctioned nearly $1 million for what a judge called a frivolous lawsuit against Hillary Clinton.
Making salary ranges public may shrink pay gaps but slow wage growth
Pay transparency laws benefit marginalized workers, but economists warn they could also diminish the negotiating power of the labor force at large.
Morgan Stanley’s favorite buys and shorts for earnings season
The firm says investors should expect a rise in price dispersion over the next couple weeks as companies report their latest quarterly results.
DOJ files second antitrust suit against Google, seeks to break up its ad business
The lawsuit targets Google’s advertising business and comes after reports that DOJ antitrust chief Jonathan Kanter had been cleared to work on Google.
Microsoft offers lackluster guidance, says new business growth slowed in December
Microsoft saw slower Azure growth and device execution challenges in a quarter where it took a $1.2 billion charge, mainly for cutting 10,000 jobs.
SpaceX completes major Starship test in prep for rocket’s first orbital launch attempt
SpaceX announced it completed a major test of its latest Starship prototype, as the company prepares for the first orbital launch of the towering rocket.
The FDA’s power to approve drugs faces sweeping challenge in lawsuit seeking to pull abortion pill from U.S. market
If the lawsuit prevails, women across the U.S. would lose access to the most common abortion method. The FDA’s powers to approve drugs would also be weakened.
Amazon adds generic prescription perk for Prime members
The add-on, called RxPass, will allow Prime members to get as many drugs as they need from a list of 50 generic medications used to treat common conditions.
